Sleep Apnea in Women: Why Risk Doubles After Menopause

• OSA is repeated airway collapse during sleep that fragments rest and drops your oxygen levels, often without you knowing.
• Women, especially after menopause, frequently present with insomnia, fatigue, morning headaches, and mood changes rather than loud snoring, so OSA is missed.
• Menopause roughly doubles OSA risk because falling estrogen and progesterone weaken airway muscle tone and reduce breathing drive.
• STOP-BANG is a quick screening questionnaire; a sleep study (in-lab or home-based) confirms the diagnosis.
• CPAP is the gold-standard treatment and improves sleep, mood, blood pressure, and diabetes control, usually within weeks.
• Untreated OSA raises the risk of high blood pressure, atrial fibrillation, stroke, worse diabetes, and road accidents.

Obstructive sleep apnoea is the repeated complete (apnoea) or partial (hypopnoea) collapse of your upper airway during sleep, even while your body keeps trying to breathe. Each event briefly wakes the brain to restart breathing and causes a dip in blood oxygen. This can happen dozens to hundreds of times a night without you ever remembering it.

The damage builds up over years. Fragmented sleep causes chronic fatigue, poor concentration, and low mood. Repeated oxygen drops and surges in the body's stress (sympathetic) nervous system strain the heart and blood vessels, raising the risk of high blood pressure in women, irregular heart rhythms, and insulin resistance.

Severity is measured by the Apnoea-Hypopnoea Index (AHI), the number of events per hour of sleep: mild is 5 to 14, moderate is 15 to 29, and severe is 30 or more. Symptoms do not always track the AHI. Some people with severe OSA feel relatively well, while others with mild OSA feel awful.

OSA is common in Indian women but rarely diagnosed. The reasons are largely cultural and clinical: the classic OSA "patient" is pictured as an overweight, middle-aged man whose wife reports loud snoring, which makes women invisible. Women more often complain of insomnia or fatigue than of obvious daytime sleepiness. Their snoring tends to be softer, many sleep alone or with a partner who does not notice, and tiredness in older women is too often brushed off as normal. Screening tools are applied less consistently to women, and referrals for sleep evaluation come later, if at all.

Women with OSA often have a different symptom picture from the textbook one. The most common complaints include:

Menopause roughly doubles a woman's OSA risk, through several overlapping mechanisms. Estrogen helps maintain the tone of the muscles that hold the upper airway open, so its decline allows the airway to collapse more easily. Progesterone is a natural respiratory stimulant, and losing it reduces your breathing drive. On top of this, the weight gain that often comes with menopause tends to settle around the middle and the neck, crowding the airway further.

The trap is that the symptoms of OSA, fatigue, disturbed sleep, mood changes, and palpitations, are exactly what we expect from menopause itself. Many women, and their doctors, attribute everything to hormones and never consider a sleep disorder, so it is worth asking whether OSA is part of the picture.

Hormone replacement therapy (HRT) modestly reduces OSA severity in some studies, but it is not adequate treatment on its own for moderate or severe disease. Women on HRT still need proper OSA evaluation if they have symptoms, and treating the OSA often clears up complaints that were blamed on menopause. Read more about hormone therapy in the Indian context.

STOP-BANG is a widely used screening questionnaire that scores eight yes-or-no items (one point each):

Continuous Positive Airway Pressure (CPAP) is the gold-standard treatment for moderate-to-severe OSA and many mild cases. A small bedside machine delivers a gentle stream of pressurised air through a mask (nasal pillows, a nasal mask, or a full-face mask) that splints the airway open all night. It works in essentially all OSA when used properly. Many women notice better sleep, mood, and concentration within days to weeks, and over months CPAP lowers blood pressure, improves diabetes control, and reduces cardiovascular and atrial fibrillation risk.

CPAP costs in India in 2026: a basic auto-adjusting machine (APAP) runs roughly Rs 35,000 to Rs 60,000, while advanced models with a built-in humidifier and connectivity cost Rs 60,000 to Rs 1,20,000. Reputable brands include ResMed, Philips Respironics, BMC Medical, and Yuwell. A heated humidifier matters in India's climate to prevent dryness. Masks cost Rs 3,000 to Rs 12,000; cushions need replacing every 3 to 6 months (Rs 1,500 to Rs 4,000), and annual supplies add Rs 3,000 to Rs 10,000. Many suppliers now offer EMI options, often comparable to a mid-range smartphone.

Sticking with CPAP is the single biggest factor in success, and also the biggest hurdle. "Adequate use" generally means at least 4 hours a night on most nights. Early struggles are normal: mask fit and comfort, air leaks, nasal congestion or dryness, a feeling of claustrophobia, and the inconvenience of travel. The good news is that with proper support, 70 to 80 percent of patients become comfortable long-term users.

Untreated OSA is a silent accelerator of cardiovascular and metabolic disease, which matters enormously given the burden of both in urban India. Each airway collapse triggers oxygen drops and stress-hormone surges that, night after night, inflame and stiffen blood vessels.

Sleep-disordered breathing in pregnancy is easy to dismiss as ordinary tiredness or "just snoring," but it deserves attention. Pregnancy hormones cause nasal congestion and mucosal swelling, the growing uterus pushes up the diaphragm, and weight gain narrows the airway, so new snoring, morning headaches, or unrefreshing sleep in the third trimester can signal OSA.

This matters because untreated OSA is associated with higher rates of gestational diabetes and a higher risk of pre-eclampsia and high blood pressure, which can in turn affect fetal growth. The risk is greater in women who start pregnancy with a higher BMI. For a fuller picture, read our dedicated guide to snoring and sleep apnoea in pregnancy.

Diagnosis uses an adjusted STOP-BANG (neck-circumference cut-offs are interpreted more cautiously in pregnancy) followed by a sleep study if needed. CPAP is the safe, first-line treatment in all trimesters because it is non-medication and does not cross the placenta. Practical steps help too: sleep on your left side (which also improves blood flow to the uterus), use a wedge or pregnancy pillow, and manage pregnancy nasal congestion with saline sprays or steam. Many women improve after delivery as hormones and weight settle, but those who were overweight beforehand may still have OSA, so a follow-up sleep study 6 to 12 weeks postpartum is wise.

These measures help, but for moderate or severe OSA they support CPAP rather than replace it:

Knowing the likely costs makes it easier to take the first step.

A few persistent myths keep women from getting diagnosed. Here is what the evidence actually says.

Book a medical or sleep-medicine review if you have ongoing sleep or daytime symptoms, particularly around or after menopause. See a doctor if you:

• WHO - Healthy ageing and noncommunicable disease prevention
• American Academy of Sleep Medicine - Obstructive sleep apnea
• NHS - Obstructive sleep apnoea
• Indian Council of Medical Research (ICMR) - ICMR-INDIAB study
• American Thoracic Society - Patient information: Sleep apnea